Cue Health ROE 2020-2023 | HLTH

Current and historical return on equity (ROE) values for Cue Health (HLTH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Cue Health ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2023-12-31 $-0.37B $0.25B -95.76%
2023-09-30 $-0.26B $0.39B -54.56%
2023-06-30 $-0.28B $0.42B -52.95%
2023-03-31 $-0.29B $0.50B -50.56%
2022-12-31 $-0.19B $0.58B -30.66%
2022-09-30 $-0.14B $0.59B -20.74%
2022-06-30 $-0.07B $0.64B -9.98%
2022-03-31 $0.03B $0.73B 6.52%
2021-12-31 $0.03B $0.71B 9.70%
2021-06-30 $-0.00B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.022B $0.071B
Cue Health Inc. is a health technology company. It offers individuals, enterprises, government agencies and healthcare provides access to lab-quality diagnostic testing at home, at work or at the point-of-care, all in a device. Cue Health Inc. is headquartered in San Diego.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $38.473B 21.40
Inspire Medical Systems (INSP) United States $6.824B 0.00
IRhythm Technologies (IRTC) United States $3.536B 0.00
Axonics (AXNX) United States $3.409B 0.00
10x Genomics (TXG) United States $3.313B 0.00
Enovis (ENOV) United States $3.044B 23.13
Azenta (AZTA) United States $2.839B 231.41
Olink Holding AB (publ) (OLK) Sweden $2.739B 0.00
Hims & Hers Health (HIMS) United States $2.545B 0.00
Privia Health (PRVA) United States $2.142B 95.00
Schrodinger (SDGR) United States $1.771B 0.00
Omnicell (OMCL) United States $1.294B 31.66
Phreesia (PHR) United States $1.264B 0.00
Definitive Healthcare (DH) United States $0.863B 0.00
Standard BioTools (LAB) United States $0.737B 0.00
Fulgent Genetics (FLGT) United States $0.615B 0.00
Talkspace (TALK) United States $0.519B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.327B 0.00
Health Catalyst (HCAT) United States $0.326B 0.00
Clover Health Investments (CLOV) United States $0.308B 0.00
Pulmonx (LUNG) United States $0.285B 0.00
MSP Recovery (LIFW) United States $0.171B 0.00
P3 Health Partners (PIII) United States $0.165B 0.00
American Well (AMWL) United States $0.160B 0.00
Butterfly Network (BFLY) United States $0.150B 0.00
Augmedix (AUGX) United States $0.146B 0.00
Outset Medical (OM) United States $0.121B 0.00
TruBridge (TBRG) United States $0.121B 5.15
111 (YI) China $0.089B 0.00
SHL Telemedicine (SHLT) Israel $0.079B 0.00
Future Health ESG (FHLT) United States $0.068B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.043B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Movano (MOVE) United States $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Strata Skin Sciences (SSKN) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
Akili (AKLI) United States $0.018B 0.00
ETAO (ETAO) United States $0.015B 0.00
Biotricity (BTCY) United States $0.014B 0.00
Centogene (CNTG) Germany $0.013B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00